Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Beckmann

Showing results (221-230 of 248) with videos related to

Pageof 25
Sort By:
Geburtshilfe Und Frauenheilkunde|February 17, 2015
Comparison of Sonography versus Digital Breast Tomosynthesis to Locate Intramammary Marker ClipsR Schulz-Wendtland, P Dankerl, G Dilbat, et al.
Breast (Edinburgh, Scotland)|July 22, 2017
Anti-Müllerian hormone (AMH) levels in premenopausal breast cancer patients treated with taxane-based adjuvant chemotherapy - A translational research project of the SUCCESS A studyElisabeth Trapp, J Steidl, B Rack, et al.
Geburtshilfe Und Frauenheilkunde|March 5, 2016
A Review of Integrative Medicine in Gynaecological OncologyM Kalder, T Müller, D Fischer, et al.
Geburtshilfe Und Frauenheilkunde|April 29, 2014
Full Field Digital Mammography (FFDM) versus CMOS Technology, Specimen Radiography System (SRS) and Tomosynthesis (DBT) - Which System Can Optimise Surgical Therapy?R Schulz-Wendtland, G Dilbat, M Bani, et al.
Geburtshilfe Und Frauenheilkunde|April 29, 2014
Breast Cancer Risk - From Genetics to Molecular Understanding of PathogenesisP A Fasching, A B Ekici, D L Wachter, et al.
Geburtshilfe Und Frauenheilkunde|September 26, 2014
Breast Cancer Risk - Genes, Environment and ClinicsP A Fasching, A B Ekici, B R Adamietz, et al.
Geburtshilfe Und Frauenheilkunde|September 27, 2014
Percent Mammographic Density and Dense Area as Risk Factors for Breast CancerC Rauh, C C Hack, L Häberle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2011
PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer--outcome on prognosisM Untch, G von Minckwitz, G E Konecny, et al.
Geburtshilfe Und Frauenheilkunde|August 1, 2017
Genetic Breast Cancer Susceptibility Variants and Prognosis in the Prospectively Randomized SUCCESS A StudyA Hein, B Rack, L Li, et al.
Plos One|June 7, 2017
The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trialB A S Jaeger, J Neugebauer, U Andergassen, et al.
Pageof 25

Showing results (221-230 of 248) with videos related to

Sort By:
Pageof 25
Geburtshilfe Und Frauenheilkunde|February 17, 2015
Comparison of Sonography versus Digital Breast Tomosynthesis to Locate Intramammary Marker ClipsR Schulz-Wendtland, P Dankerl, G Dilbat, et al.
Breast (Edinburgh, Scotland)|July 22, 2017
Anti-Müllerian hormone (AMH) levels in premenopausal breast cancer patients treated with taxane-based adjuvant chemotherapy - A translational research project of the SUCCESS A studyElisabeth Trapp, J Steidl, B Rack, et al.
Geburtshilfe Und Frauenheilkunde|March 5, 2016
A Review of Integrative Medicine in Gynaecological OncologyM Kalder, T Müller, D Fischer, et al.
Geburtshilfe Und Frauenheilkunde|April 29, 2014
Full Field Digital Mammography (FFDM) versus CMOS Technology, Specimen Radiography System (SRS) and Tomosynthesis (DBT) - Which System Can Optimise Surgical Therapy?R Schulz-Wendtland, G Dilbat, M Bani, et al.
Geburtshilfe Und Frauenheilkunde|April 29, 2014
Breast Cancer Risk - From Genetics to Molecular Understanding of PathogenesisP A Fasching, A B Ekici, D L Wachter, et al.
Geburtshilfe Und Frauenheilkunde|September 26, 2014
Breast Cancer Risk - Genes, Environment and ClinicsP A Fasching, A B Ekici, B R Adamietz, et al.
Geburtshilfe Und Frauenheilkunde|September 27, 2014
Percent Mammographic Density and Dense Area as Risk Factors for Breast CancerC Rauh, C C Hack, L Häberle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2011
PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer--outcome on prognosisM Untch, G von Minckwitz, G E Konecny, et al.
Geburtshilfe Und Frauenheilkunde|August 1, 2017
Genetic Breast Cancer Susceptibility Variants and Prognosis in the Prospectively Randomized SUCCESS A StudyA Hein, B Rack, L Li, et al.
Plos One|June 7, 2017
The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trialB A S Jaeger, J Neugebauer, U Andergassen, et al.
Pageof 25